Company profile: Cognivia
1.1 - Company Overview
Company description
- Provider of analytical tools and services to optimize and speed clinical development of novel medicines, including Placebell to reduce data variability by addressing placebo response and patient heterogeneity; Compl-AI to predict non-adherence and dropout risks to aid patient engagement; and an Expert Analysis Service to detect and explain clinical site variability and help adjust data for clearer study results.
Products and services
- Compl-AI: A predictive-model-based tool that evaluates patient characteristics to forecast non-adherence and dropout risks, informing patient engagement strategies in clinical trials
- Expert Analysis Service: An expert-led analytic service that detects and explains sources of clinical site variability, helping researchers adjust data for clearer study results
- Placebell: An algorithm-driven tool using proprietary questionnaires and algorithms to reduce data variability by addressing placebo response and patient heterogeneity within clinical trials
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cognivia
Summit Biosciences
HQ: United States
Website
- Description: Provider of specialty pharmaceutical development, manufacturing and commercialization of generic and innovative nasal spray drug products, also offering contract development and manufacturing services to partners and clients for a wide variety of nasally delivered products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Summit Biosciences company profile →
Veranova
HQ: United States
Website
- Description: Provider of research, development, and manufacturing of sophisticated, complex active pharmaceutical ingredients (APIs) for pharmaceutical and biotech industries, applying scientific expertise and diversified talent to create fresh approaches to resolving business issues and enhancing stakeholder value.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Veranova company profile →
Lexitas
HQ: United States
Website
- Description: Provider of full-service ophthalmology CRO solutions for pharma and biotech, including end-to-end clinical operations, global site relationships and international regulatory expertise, medical and regulatory writing, medical monitoring, reading center image assessments, and data management, biostatistics, and statistical programming.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lexitas company profile →
Prime Global
HQ: United States
Website
- Description: Provider of medical communications services via a group of seven full-service medical communications agencies and two specialist consultancies, with a people-first focus on creative, innovative science communication.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prime Global company profile →
The Medicine Maker
HQ: United Kingdom
Website
- Description: Provider of a publication for persons involved in the development and manufacture of pharmaceuticals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full The Medicine Maker company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cognivia
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cognivia
2.2 - Growth funds investing in similar companies to Cognivia
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cognivia
4.2 - Public trading comparable groups for Cognivia
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →